Evidence map›Paper›PMID 34920761›Full record

ArticleCell & bioscience2021

Microinjection of antisense oligonucleotides into living mouse testis enables lncRNA function study.

Zhaohui Chen, Li Ling, Xiaolian Shi, Wu Li, Huicong Zhai, Zhenlong Kang, Bangjin Zheng, Jiaqi Zhu, Suni Ye, Hao Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Zhaohui Chen *State Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Li Ling *State Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Xiaolian Shi *State Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Wu Li *State Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Huicong Zhai *State Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Zhenlong KangState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Bangjin ZhengState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Jiaqi ZhuState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Suni YeState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Hao WangState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Lingxiu TongState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China.
Juan NiDepartment of Obstetrics and Gynecology, the Affiliated Hospital of Hangzhou Normal University, 310015, Zhejiang, China.
Chaoyang HuangDepartment of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, 310014, Zhejiang, China. wzy7512@zju.edu.cn.
Yang LiState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China. li_yang@njmu.edu.cn.
Ke ZhengState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166, Nanjing, China. kezheng@njmu.edu.cn.ORCID http://orcid.org/0000-0001-9762-6605
Nanjing Medical University · CNAffiliated Hospital of Hangzhou Normal University · CNFirst Affiliated Hospital Zhejiang University · CN

Funding

national natural science foundation of china 31771653national natural science foundation of china 31970791national natural science foundation of china 82001613postdoctoral research foundation of china 2020M671540Zhejiang Medical Science and Technology Project 2019KY499
6 · The paper itself

Abstract

backgroundLong non-coding RNAs (lncRNAs) have been the focus of ongoing research in a diversity of cellular processes. LncRNAs are abundant in mammalian testis, but their biological function remains poorly known.

resultsHere, we established an antisense oligonucleotides (ASOs)-based targeting approach that can efficiently knock down lncRNA in living mouse testis. We cloned the full-length transcript of lncRNA Tsx (testis-specific X-linked) and defined its testicular localization pattern. Microinjection of ASOs through seminiferous tubules in vivo significantly lowered the Tsx levels in both nucleus and cytoplasm. This effect lasted no less than 10 days, conducive to the generation and maintenance of phenotype. Importantly, ASOs performed better in depleting the nuclear Tsx and sustained longer effect than small interfering RNAs (siRNAs). In addition to the observation of an elevated number of apoptotic germ cells upon ASOs injection, which recapitulates the documented description of Tsx knockout, we also found a specific loss of meiotic spermatocytes despite overall no impact on meiosis and male fertility.

conclusionsOur study detailed the characterization of Tsx and illustrates ASOs as an advantageous tool to functionally interrogate lncRNAs in spermatogenesis.

Indexed as

ASO (antisense oligonucleotide)Knock downlncRNA (long non-coding RNA)Testis injectionTsx

Identifiers

PMID34920761
PMCPMC8684201
OpenAlexW4225634771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.